HighTower Advisors’s iBio IBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding IBIO
SM
WAM
TRCT
HighTower Advisors's IBIO Position: Q4 2023 in Review
HighTower Advisors sold out of iBio (IBIO) in Q4 2023, closing a stake of 554 shares — an estimated $3K sold.
HighTower Advisors first reported a position in IBIO in Q2 2016 and held it in 23 quarters. The position peaked at $81K in Q2 2016. 21 funds tracked by Wall St. Rank hold IBIO as of Q4 2023.
- HighTower Advisors reported no remaining iBio position as of Q4 2023 after selling out during the quarter.
- HighTower Advisors sold 554 iBio shares in Q4 2023, an estimated $3K.
- HighTower Advisors first reported a position in iBio in Q2 2016 and held it in 23 quarters.
- HighTower Advisors's iBio position peaked at $81K in Q2 2016.
- 21 funds tracked by Wall St. Rank held iBio as of Q4 2023.
Based on HighTower Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.